Mogibacterium Details: NCBI 86331, gram-negative or unknown [genus]

| Mogibacterium| Mogibacterium Nakazawa et al. 2000

  1. Gut Microbiota Composition:

    • Mogibacterium is one of the many genera found in the gut microbiota. The gut microbiota is known to play a crucial role in various physiological processes, including digestion, metabolism, and immune system regulation.
  2. Anaerobic Bacteria:

    • Mogibacterium species are anaerobic bacteria, meaning they thrive in environments with low oxygen levels. The gut, particularly the colon, provides anaerobic conditions suitable for the growth of these bacteria.
  3. Metabolic Activities:

    • The specific metabolic activities of Mogibacterium in the gut are not extensively studied. Generally, bacteria in the gut contribute to the fermentation of dietary fibers and the production of short-chain fatty acids (SCFAs), which can have implications for gut health.
  4. Associations with Disease:

    • The associations of Mogibacterium with specific health conditions or diseases are not well-established due to limited research. The health impacts of bacteria in the gut often depend on their relative abundance, interactions with other microbial species, and the overall context of the gut microbiota.
  5. Microbiota Dysbiosis:

    • Changes in the composition and diversity of the gut microbiota, including the abundance of Mogibacterium, have been associated with conditions such as inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and metabolic disorders. However, direct causation and the specific role of Mogibacterium in these conditions are areas of ongoing investigation.
  6. Research Gaps:

    • Mogibacterium is considered part of the "core" human gut microbiota, but detailed research on its functional roles and health impacts is limited. The genus is not as extensively studied as some other members of the gut microbiota.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Mogibacterium

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 1.94 10 2829 0 1319 321.5 125 508.8 0 630 0 %ile 100 %ile
biomesight 78.46 0 270 10 530 0 2914 459.9 160 1252.2 0 600 0 %ile 90.9 %ile
thorne 100 7 153 0 115 45.6 38 35.2 4 70 0 %ile 100 %ile
thryve 74.55 0 183 28 386 0 2145 337.6 127 922.2 0 481 11.5 %ile 90.1 %ile
ubiome 62.23 0 233 15 1151 0 5315 952.5 233 2225.7 0 1275 0 %ile 91.9 %ile

External Reference Ranges for Mogibacterium

Mogibacterium (NCBI 86331) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 11.73 31.65 0.0012 0.0032
Statistic by Lab Source for Mogibacterium
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 66.667 %   0.048 %  0.033 % 10.0 15
BiomeSight 83.508 %   0.046 %  0.119 % 2476.0 2965
BiomeSightRdp 80.645 %   0.037 %  0.062 % 25.0 31
bugspeak 100 %   0.005 %  % 1.0 1
CerbaLab 100 %   0.01 %  0.005 % 3.0 3
CosmosId 18.75 %   0.004 %  0.004 % 6.0 32
custom 3.279 %   0.007 %  0.006 % 2.0 61
es-xenogene 6.897 %   0.01 %  0.007 % 2.0 29
Medivere 100 %   0.024 %  0.015 % 7.0 7
SequentiaBiotech 2.778 %   0.016 %  % 1.0 36
Thorne 86.538 %   0.004 %  0.005 % 90.0 104
Thryve 75.862 %   0.032 %  0.086 % 1056.0 1392
Tiny 50 %   0.001 %  % 1.0 2
uBiome 61.995 %   0.095 %  0.223 % 491.0 792

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Common Supplements sodium butyrate 1 Studies recorded. The consensus is Decreases👶, Click for details.
Common Supplements Tributyrin 1 Studies recorded. The consensus is Decreases👶, Click for details.
Diet Style dietary fiber 1 Studies recorded. The consensus is Increases📓, Click for details.
Diet Style high fiber diet 1 Studies recorded. The consensus is Increases📓, Click for details.
Diet Style low protein diet 1 Studies recorded. The consensus is Increases👶, Click for details.
Food (excluding seasonings) brown rice 1 Studies recorded. The consensus is Increases📓, Click for details.
Food (excluding seasonings) whey 1 Studies recorded. The consensus is Decreases👶, Click for details.
Prebiotics and similar Psyllium (Plantago Ovata Husk) 1 Studies recorded. The consensus is Decreases👶, Click for details.
Prebiotics and similar resistant starch 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics Pediococcus pentosaceus 1 Studies recorded. The consensus is Decreases👶, Click for details.

Foods Containing the Mogibacterium bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Cheese with dietary fibers Weight: 1.505 Swiss-Dutch-type cheese Weight: 0.0525 Gruyere cheese Weight: 0.01246 Kokonte, Ghana Weight: 0.0114 Dehulled maize dough, Ghana Weight: 0.01121 Cheddar cheese Weight: 0.01015 Palm wine Weight: 0.007768 Brie cheese Weight: 0.007008 Jarlsberg cheese Weight: 0.006729 Dehulled maize dough fermented 12h, Ghana Weight: 0.005589 Obushera, Uganda Weight: 0.003544 yoghurt fermentation Weight: 0.002928

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.